Reuters logo
EXCLUSIVE - Human Genome agrees to GlaxoSmithKline takeover - sources
July 16, 2012 / 2:38 AM / 5 years ago

EXCLUSIVE - Human Genome agrees to GlaxoSmithKline takeover - sources

REUTERS - Human Genome Sciences Inc HGSI.O has agreed to be acquired by GlaxoSmithKline Plc (GSK.L), subject to approval of some last-minute details, for about $14 a share in cash, two sources familiar with the situation said on Sunday.

The Human Genome Sciences Laboratories and Offices building is seen in Rockville, Maryland, May 17, 2012. REUTERS/Jose Luis Magana/Files

The deal is expected to be announced before the U.S. stock market opens on Monday, the sources added.

The price represents an increase to Glaxo’s previous offer of $13 a share.

Human Genome shares ended trading on Friday at $13.58.

Reporting by Greg Roumeliotis in New York

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below